Diagnostic performance of fine-needle aspiration in soft tissue tumors: Application of the World Health Organization System for Reporting Soft Tissue Cytopathology and risk of malignancy assessment.

IF 2.6 3区 医学 Q3 ONCOLOGY
Pawel Gajdzis, Hervé J Brisse, Jerzy Klijanienko
{"title":"Diagnostic performance of fine-needle aspiration in soft tissue tumors: Application of the World Health Organization System for Reporting Soft Tissue Cytopathology and risk of malignancy assessment.","authors":"Pawel Gajdzis, Hervé J Brisse, Jerzy Klijanienko","doi":"10.1002/cncy.22897","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Recently, a new World Health Organization Reporting System for Soft Tissue Cytopathology (WHO System) was introduced. To analyze the value of this system, routine fine-needle aspiration soft tissue tumor (STT) cases were reviewed.</p><p><strong>Methods: </strong>Cytology samples of STTs collected between 1954 and 2022 at the Institut Curie were used (2214 cases, including 1376 primary tumors). All specimens were classified according to the predominant cytomorphological pattern and the WHO System. The diagnostic accuracy and risk of malignancy (ROM) in each category were calculated.</p><p><strong>Results: </strong>Final diagnoses revealed 1236 malignancies and 978 benign or low-risk tumors. The original cytological evaluation led to 21 false-negative results (0.85%) and 29 false-positive results (1.17%). Sensitivity, specificity, positive predictive value, and negative predictive value were 98.3%, 92.1%, 97.5%, and 94.2%, respectively. Overall diagnostic accuracy was 94.2%. The ROM calculated according to the WHO System was 29.87%, 2.49%, 39.62%, 51.43%, 68.42%, and 97.69% in the nondiagnostic, benign, atypical, soft tissue neoplasm of uncertain malignant potential, suspicious for malignancy, and malignant categories, respectively; however, it varied broadly depending on the morphological pattern (62.78% in spindle cell tumors, 84.58% in myxoid tumors, 3.00% in lipomatous tumors, 78.15% in epithelioid tumors, 94.26% in pleomorphic tumors, and 100% in round cell tumors).</p><p><strong>Conclusions: </strong>Cytology of STTs is a powerful diagnostic method. Some cytological patterns overlap in different morphological groups, and the possibility of false-negative and false-positive diagnoses may persist. This analysis evidenced utility of the WHO System, especially when combined with morphological pattern assessment. Subclassification in particular diagnostic categories allowed for calculation of the ROM, which is crucial for optimal patient management.</p>","PeriodicalId":9410,"journal":{"name":"Cancer Cytopathology","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Cytopathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/cncy.22897","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Recently, a new World Health Organization Reporting System for Soft Tissue Cytopathology (WHO System) was introduced. To analyze the value of this system, routine fine-needle aspiration soft tissue tumor (STT) cases were reviewed.

Methods: Cytology samples of STTs collected between 1954 and 2022 at the Institut Curie were used (2214 cases, including 1376 primary tumors). All specimens were classified according to the predominant cytomorphological pattern and the WHO System. The diagnostic accuracy and risk of malignancy (ROM) in each category were calculated.

Results: Final diagnoses revealed 1236 malignancies and 978 benign or low-risk tumors. The original cytological evaluation led to 21 false-negative results (0.85%) and 29 false-positive results (1.17%). Sensitivity, specificity, positive predictive value, and negative predictive value were 98.3%, 92.1%, 97.5%, and 94.2%, respectively. Overall diagnostic accuracy was 94.2%. The ROM calculated according to the WHO System was 29.87%, 2.49%, 39.62%, 51.43%, 68.42%, and 97.69% in the nondiagnostic, benign, atypical, soft tissue neoplasm of uncertain malignant potential, suspicious for malignancy, and malignant categories, respectively; however, it varied broadly depending on the morphological pattern (62.78% in spindle cell tumors, 84.58% in myxoid tumors, 3.00% in lipomatous tumors, 78.15% in epithelioid tumors, 94.26% in pleomorphic tumors, and 100% in round cell tumors).

Conclusions: Cytology of STTs is a powerful diagnostic method. Some cytological patterns overlap in different morphological groups, and the possibility of false-negative and false-positive diagnoses may persist. This analysis evidenced utility of the WHO System, especially when combined with morphological pattern assessment. Subclassification in particular diagnostic categories allowed for calculation of the ROM, which is crucial for optimal patient management.

软组织肿瘤细针穿刺的诊断性能:世界卫生组织软组织细胞病理学报告系统的应用及恶性肿瘤风险评估。
背景:最近,世界卫生组织推出了新的软组织细胞病理学报告系统(WHO系统)。为了分析该系统的价值,我们回顾了常规细针穿刺软组织肿瘤(STT)病例:方法:采用居里研究所在 1954 年至 2022 年期间收集的软组织肿瘤细胞学样本(2214 例,包括 1376 例原发性肿瘤)。所有标本均根据主要细胞形态学模式和世界卫生组织系统进行分类。结果:结果:最终诊断结果显示有1236例恶性肿瘤和978例良性或低风险肿瘤。最初的细胞学评估导致 21 个假阴性结果(0.85%)和 29 个假阳性结果(1.17%)。敏感性、特异性、阳性预测值和阴性预测值分别为 98.3%、92.1%、97.5% 和 94.2%。总体诊断准确率为 94.2%。根据世界卫生组织系统计算的 ROM 在无诊断性、良性、非典型、恶性潜能不确定的软组织肿瘤、恶性可疑和恶性类别中分别为 29.87%、2.49%、39.62%、51.43%、68.42% 和 97.69%;然而,根据形态学模式的不同,ROM 也有很大差异(纺锤形细胞肿瘤为 62.78%,恶性可疑肿瘤为 62.69%)。纺锤形细胞瘤为 62.78%,肌瘤为 84.58%,脂肪瘤为 3.00%,上皮样瘤为 78.15%,多形性肿瘤为 94.26%,圆形细胞瘤为 100%):结论:STT 的细胞学检查是一种强有力的诊断方法。结论:STT 细胞学检查是一种强有力的诊断方法,但在不同形态组别中,某些细胞学形态会出现重叠,因此仍有可能出现假阴性和假阳性诊断。这项分析证明了世界卫生组织系统的实用性,尤其是在与形态学模式评估相结合时。通过对特定诊断类别进行细分,可以计算出ROM,这对优化患者管理至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Cytopathology
Cancer Cytopathology 医学-病理学
CiteScore
7.00
自引率
17.60%
发文量
130
审稿时长
1 months
期刊介绍: Cancer Cytopathology provides a unique forum for interaction and dissemination of original research and educational information relevant to the practice of cytopathology and its related oncologic disciplines. The journal strives to have a positive effect on cancer prevention, early detection, diagnosis, and cure by the publication of high-quality content. The mission of Cancer Cytopathology is to present and inform readers of new applications, technological advances, cutting-edge research, novel applications of molecular techniques, and relevant review articles related to cytopathology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信